President Joe Biden on Friday indicated that his administration has pre-ordered Pfizer Inc.’s PFE, +10.86% oral antiviral Paxlovid. “Last night, we received promising news about another potent potential COVID treatment, a pill developed by Pfizer that may dramatically reduce the risk of being hospitalized or dying when taken shortly after infection,” he said during a brief speech at the White House. “We have already secured millions of doses, and the therapy would be another tool in our toolbox to protect people from … the worst outcomes of COVID.”
This article was originally published by Marketwatch.com. Read the original article here.
